Massive cuts at the FDA have hit staff tied to drug reviews and user fees, putting future approvals in jeopardy, according to multiple reports.

While it’s not unusual for certain positions to turn over with a new administration, the number of senior-level FDA staffers ...

“What’s happening … is a reflection of the sprawling bureaucracy that’s actually making America sick and costing hundreds of ...

Dr Peter Marks is resigning as director of the FDA's Center for Biologics Evaluation and Research by April 5 due to objections to RFK Jr.

More top vaccine regulators at the FDA have either left or been forced out, which could hobble the agency's ability to ...

The FDA has delayed granting full approval of Novavax's COVID-19 vaccine despite it being on track to be cleared until ...

Dr Sara Brenner, the FDA's principal deputy commissioner, has paused the approval process for Novavax's Covid-19 vaccine by ...

Amid a period of great upheaval at the agency, the FDA has missed its deadline to decide on approval for Novavax’s COVID-19 ...

The latest cuts, which are part of a larger reduction of 10,000 at the Department of Health and Human Services, were ...

Ex-vaccine regulator Peter Marks promoted "ineffective therapy that gave patients false hope, eroded trust in the regulatory ...